PharmaShots | Incisive News in 3 Shots

Subscribe Now

Review in the US

AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review for Chronic Kidney Disease

AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review for Chronic Kidney Disease

January 6, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us